Art. 4 Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009…

Subject matter of protection

In forcesince 6 May 2009cited 29×

Within the limits of the protection conferred by the basic patent, the protection conferred by a certificate shall extend only to the product covered by the authorisation to place the corresponding medicinal product on the market and for any use of the product as a medicinal product that has been authorised before the expiry of the certificate.

The 10 that are cited most themselves, of 29.

  • Judgment of the Court (Fourth Chamber) of 24 November 2011. Medeva BV v Comptroller General of Patents, Designs and Trade Marks.Decision

    … Moreover, in accordance with Article 4 of Regulation No 469/2009, a SPC is intended to protect the ‘product’ covered by the MA, not the medicinal product as such.

    24 Nov 2011 · 62010CJ0322

  • Judgment of the Court (Fourth Chamber) of 24 November 2011. Georgetown University and Others v Comptroller General of Patents, Designs and TDecision

    … Moreover, in accordance with Article 4 of Regulation No 469/2009, a SPC is intended to protect the ‘product’ covered by the MA, not the medicinal product as such (Medeva, paragraph 37).

    24 Nov 2011 · 62010CJ0422

  • Judgment of the Court (Eighth Chamber) of 15 January 2015. Arne Forsgren v Österreichisches Patentamt.Decision

    In addition, Article 4 of Regulation No 469/2009 provides that the protection conferred by the certificate is to extend only to the product covered by the marketing authorisation ‘for any use of the product as a medicinal product that …

    15 Jan 2015 · 62013CJ0631

  • Judgment of the Court (Fourth Chamber), 19 July 2012. Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.Decisioninterprets

    That refusal was challenged before the High Court of Justice (Chancery Division — Patents Court) by Neurim, which argued, in essence, that the relevant MA for the application of Article 3(d) of the SPC Regulation is that which concerns …

    19 Jul 2012 · 62011CJ0130

  • Order of the Court (Fourth Chamber) of 25 November 2011. University of Queensland and CSL Ltd v Comptroller General of Patents, Designs and Decision

    In accordance with Article 5 of Regulation No 469/2009, a SPC thus granted in connection with such a product confers, upon the expiry of the patent, the same rights as were conferred by the basic patent in relation to the product, within …

    25 Nov 2011 · 62010CO0630

  • Judgment of the Court (Grand Chamber) of 25 July 2018. Teva UK Ltd and Others v Gilead Sciences Inc.Decision

    That interpretation is borne out by Article 4 of Regulation No 469/2009, which provides that the protection granted by the SPC extends only to the product covered by the MA granted for the corresponding medicinal product and for any use of …

    25 Jul 2018 · 62017CJ0121

  • Order of the Court (Fourth Chamber) of 25 November 2011. Daiichi Sankyo Company v Comptroller General of Patents, Designs and Trade Marks.Decision

    That being so, it should be noted, as the Czech Government correctly submitted, that, in accordance with Article 5 of Regulation No 469/2009, a SPC granted in connection with a product confers, upon the expiry of the basic patent, the same …

    25 Nov 2011 · 62011CO0006

  • Judgment of the Court (Fourth Chamber) of 21 March 2019. Abraxis Bioscience LLC v Comptroller General of Patents.Decision

    The case-law arising from the judgment of 19 July 2012, Neurim Pharmaceuticals (1991) (C‑130/11, EU:C:2012:489) cannot call into question such an interpretation. In that judgment, the Court held that Articles 3 and 4 of Regulation No …

    21 Mar 2019 · 62017CJ0443

  • Judgment of the Court (Third Chamber), 12 December 2013. Actavis Group PTC EHF and Actavis UK Ltd v Sanofi.Decision

    In accordance with Article 5 of Regulation No 469/2009, an SPC granted in connection with a product confers, upon the expiry of the basic patent, the same rights as were conferred by that patent in relation to the product, within the …

    12 Dec 2013 · 62012CJ0443

  • Order of the Court (Eighth Chamber), 14 November 2013. Glaxosmithkline Biologicals SA and Glaxosmithkline Biologicals, Niederlassung der SmiDecision

    This reference for a preliminary ruling concerns the interpretation of Article 1(b) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for …

    14 Nov 2013 · 62013CO0210